Tinos Therapeutics, Inc. logo

Tinos Therapeutics, Inc.

6 Marks
Corp.
First Filed:May 1, 2023Latest Filed:Jan 29, 2026Address:34 Boyce Avenue, Barrington, RI 02806, US

Portfolio Overview

Top Classes

Class 42
Software, IT Services & Scientific Research
5(83%)
Class 5
Pharmaceuticals
2(33%)
Class 44
Medical, beauty and agricultural services
2(33%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

6 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
EPICODE
EPICODE
Service Mark
Word
PENDING
Owner:
Serial:99622520
Filed:Jan 29, 2026
Classes:42, 44
Goods & Services
Class 042: Pharmaceutical research and development; Class 044: Genetic analysis for medical purposes
TINOS THERAPEUTICS
TINOS THERAPEUTICS
Trademark
Word
PENDING
Owner:
Serial:99622513
Filed:Jan 29, 2026
Classes:5, 40, 42, +1
Goods & Services
Class 005: pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); pharmaceuticals, namely, viral vector therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); Class 040: Custom manufacturing of pharmaceuticals; Class 042: Pharmaceutical products development; Pharmaceutical research and development; Class 044: Genetic analysis for medical purposes
MODIGEN
MODIGEN
Service Mark
Word
PENDING
Owner:
Serial:99553660
Filed:Dec 17, 2025
Classes:42
Goods & Services
Class 042: Pharmaceutical research and development, namely, research and development of modified RNA-derived antigens for the treatment of cancer
EPICODE
EPICODE
Service Mark
Word
ABANDONED
Owner:
Serial:99342363
Filed:Aug 18, 2025
Classes:42
Goods & Services
Class 042: Providing temporary use of online non-downloadable neural networks and software for drug discovery, pharmaceutical research and development, and genetic analysis
TINOS THERAPEUTICS
TINOS THERAPEUTICS
Service Mark
Word
ABANDONED
Owner:
Serial:99342360
Filed:Aug 18, 2025
Classes:42
Goods & Services
Class 042: Providing temporary use of online non-downloadable neural networks and software for drug discovery, pharmaceutical research and development, and genetic analysis
TINOS THERAPEUTICS
TINOS THERAPEUTICS
Trademark
Word
PENDING
Owner:
Serial:97914745
Filed:May 1, 2023
Classes:5
Goods & Services
pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); "THERAPEUTICS"